STAT(@statnews):Research shows that the U.S. pays, on average, anywhere from three to four times as much for brand-name drugs compared with other wealthy countries. But a breaking point is imminent, one that makes government intervention to curb health care costs inevitable, experts insist.

STAT

@statnews

Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here:

Joined July 2015

4.7K Following 165.3K Followers

STAT@statnews

2026.10.11 13:54

Research shows that the U.S. pays, on average, anywhere from three to four times as much for brand-name drugs compared with other wealthy countries. But a breaking point is imminent, one that makes government intervention to curb health care costs inevitable, experts insist.